Primary and Salvage Cryotherapy for Prostate Cancer

Urologic Clinics of North America

Volumn 37, Issue 1, 2010, Pages 67-82

  Finley, David S ^a   Pouliot, Frederic ^a   Miller, David C ^b   Belldegrun, Arie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cryoablation; Cryotherapy; Focal ablation; Focal therapy; Prostate; Prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; BRACHYTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COOLING; CRYOABLATION; CRYOTHERAPY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MINIMALLY INVASIVE PROCEDURE; PATIENT SAFETY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RECTUM FISTULA; REVIEW; SALVAGE THERAPY; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; URETHRA STRICTURE; URINE INCONTINENCE; URINE RETENTION;

CRYOTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 75449115968     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2009.11.007     Document Type: Review

References (95)

1. Cooper I.S., and Lee A.S. Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 133 (1961) 259
2. Gonder M.J., Soanes W.A., and Shulman S. Cryosurgical treatment of the prostate. Invest Urol 3 4 (1966) 372-378
3. Millennium Research Group. US markets for urological devices (2006), Millennium Research Group, Inc, Toronto, Ontario, Canada
4. Babaian R.J., Donnelly B., Bahn D., et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 180 (2008) 1993-2004
5. Cohen J.K., Miller R.J., Ahmed S., et al. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 71 (2008) 515-518
6. Jones J.S., Rewcastle J.C., Donnelly B.J., et al. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol 180 (2008) 554-558
7. Pisters L.L., Rewcastle J.C., Donnelly J.C., et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 180 (2008) 559-564
8. Gonder M.J., Soanes W.A., and Smith V. Experimental prostate cryosurgery. Invest Urol 14 (1964) 610-619
9. Baust J.G., Gage A.A., Klossner D., et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat 6 (2007) 97-109
10. Hoffmann N.E., and Bischof J.C. The cryobiology of cryosurgical injury. Urology 60 (2002) 40-49
11. Cooper I.S., and Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med 274 (1966) 15-18
12. Gage A.A., and Baust J.G. Cryosurgery for tumors. J Am Coll Surg 205 (2007) 342-356
13. Baust J.G., and Gage A.A. The molecular basis of cryosurgery. BJU International 95 (2005) 1187-1191
14. Tatsutani K., Rubinsky B., Onik G., et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 48 (1996) 441-447
15. Mazur P. Physical-chemical factors underlying cell injury in cryosurgical freezing. In: Rand R., Rinfret A., and von Leden H. (Eds). "Cryosurgery" (1968), Thomas, Springfield (IL) 32-51
16. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol 143 (1984) C125-C142
17. Farrant J., and Walter C.A. The cryobiological basis for cryosurgery. J Dermatol Surg Oncol 3 (1977) 403-407
18. Gage A.A., and Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 37 (1998) 171-186
19. Whittaker D.K. Ice crystals formed in tissue during cryosurgery. II. Electron microscopy. Cryobiology 11 (1974) 202-217
20. Onik G.M., Lee F., and Bahn D. Cryosurgical techniques, caveats, and refinements. In: Onik G.M., Rubinsky B., Watson G., and Ablin R.J. (Eds). Percutaneous prostate cryoablation (1994), Quality Medical Publishing, St. Louis (MO) 78-84 chapter 6
21. Shinohara K., Connolly J.A., Presti Jr. J.C., et al. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol 156 (1996) 115-120 [discussion: 120-1]
22. Larson T.R., Robertson D.W., Corica A., et al. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 55 (2000) 547-552
23. Pisters L.L., von Eschenbach A.C., Scott S.M., et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157 (1997) 921-925
24. Wong W.S., Chinn D.O., Chinn M., et al. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 79 (1997) 963-974
25. Mouraviev V., and Polascik T.J. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol 16 (2006) 152-156
26. Bales G.T., Williams M.J., Sinner M., et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology 46 (1995) 676-680
27. Baust J., Gage A.A., Ma H., et al. Minimally invasive cryosurgery-technological advances. Cryobiology 34 (1997) 373-384
28. Miller Jr. R.J., Cohen J.K., Shuman B., et al. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma. Cancer 77 (1996) 1510-1514
29. Cespedes R.D., Pisters L.L., von Eschenbach A.C., et al. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol 157 (1997) 237-240
30. Leibovici D., Zisman A., Lindner A., et al. PSA elevation during prostate cryosurgery and subsequent decline. Urol Oncol 23 (2005) 8-11
31. Wieder J., Schmidt J.D., Casola G., et al. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 154 (1995) 435-441
32. Greene G.F., Pisters L.L., Scott S.M., et al. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol 160 (1998) 86-90
33. Ellis D.S. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 60 (2002) 34-39
34. Shinohara K., Rhee B., Presti Jr. J.C., et al. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 158 (1997) 2206-2209 [discussion 2209-10]
35. Benoit R.M., Cohen J.K., and Miller Jr. R.J. Cryosurgery for prostate cancer: new technology and indications. Curr Urol Rep 1 (2000) 41
36. Koppie T.M., Shinohara K., Grossfeld G.D., et al. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol 162 (1999) 427-432
37. Long J.P., Bahn D., Lee F., et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57 (2001) 518-523
38. Ghafar M.A., Johnson C.W., De La Taille A., et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 166 (2001) 1333-1337 [discussion: 1337-8]
39. Bahn D.K., Lee F., Badalament R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (2002) 3-11
40. Han K.R., Cohen J.K., Miller R.J., et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170 (2003) 1126-1130
41. Chinn D.O., Wong W.W., Chinn M., et al. Temperature monitored prostate cryosurgery: 8 year accrued clinical experience. J Urol 171 (2004) 219
42. Donnelly B.J., Saliken J.C., Ernst D.S., et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 8 (2005) 235-242
43. Polascik T.J., Nosnik I., Mayes J.M., et al. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology 70 (2007) 117-121
44. Miller DC, Pisters LL, Belldegrun AS. Cryotherapy for prostate cancer, Chapter 101. In: Wein AJ, Kavoussi LR, Novick AC, et al, editors. Campbell-Walsh Urology, 9th edition. Saunders, 2007.
45. Prepelica K.L., Okeke Z., Murphy A., et al. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 103 (2005) 1625-1630
46. Connolly J.A., Shinohara K., and Carroll P.R. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol 15 (1997) 244-249
47. Donnelly B.J., Saliken J.C., Ernst D.S., et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60 (2002) 645-649
48. Ellis D.S., Manny Jr. T.B., and Rewcastle J.C. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology 69 (2007) 306-310
49. Bahn D.K., Lee F., Solomon M.H., et al. Prostate cancer: US-guided percutaneous cryoablation: work in progress. Radiology 194 (1995) 551-556
50. Bostwick D.G., and Meiers I. Diagnosis of prostatic carcinoma after therapy. Arch Pathol Lab Med 131 (2007) 360-371
51. Katz A, Jones S, Ellis D, et al. Primary prostate cryoablation: updated results from 2558 patients tracked with the COLD registry. Abstract Number: 08-AB-95457-AUA.
52. Bostwick D.G., Waters D.J., Farley E.R., et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 70 Suppl 6 (2007) 42-44
53. Barqawi A.B., and Crawford E.D. The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 13 5 (2007) 313-317
54. Barzell W.E., and Melamed M.R. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urology 70 Suppl 6 (2007) 27-35
55. Eggener S.E., Scardino P.T., Carroll P.R., et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178 (2007) 2260-2267
56. Polascik T.J., Mayes J.M., and Mouraviev V. From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer. Oncology (Williston Park) 22 8 (2008) 900-906 [discussion: 906-7, 914]
57. Ahmed H.U., Moore C., and Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol 18 3 (2009) 219-232
58. Iczkowski K.A., Hossain D., Torkko K.C., et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology 71 6 (2008) 1166-1171
59. Yoon G.S., Wang W., Osunkoya A.O., et al. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 179 6 (2008) 2203-2206 [discussion: 2206]
60. Onik G., Narayan P., Vaughan D., et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 60 (2002) 109-114
61. Levine M.A., Ittman M., and Melamed J. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159 2 (1998) 471-475
62. Lambert E.H., Bolte K., Masson P., et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 69 (2007) 1117-1120
63. Onik G., Vaughan D., Lotenfoe R., et al. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow up. Seminars and Original Investigations. Urol Oncol 26 (2008) 500-505
64. Ellis D, Jones S, Pisters L, et al. Subtotal/partial gland prostate cryoablation: results of 341 patients from multiple centers tracked with the COLD registry. Abstract Number: 08-AB-95484-AUA.
65. Mettlin C.J., Murphy G.P., McDonald C.J., et al. The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 86 (1999) 1877-1882
66. Mettlin C.J., Murphy G.P., Rosenthal D.S., et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83 (1998) 1679-1684
67. Nguyen P.L., D'Amico A.V., Lee A.K., et al. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure. Cancer 110 (2007) 1417-1428
68. Allen G.W., Howard A.R., Jarrard D.F., et al. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer 110 (2007) 1405-1416
69. Touma N.J., Izawa J.I., and Chin J.L. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 173 (2005) 373-379
70. Mouraviev V., Evans B., and Polascik T.J. Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach. Prostate Cancer Prostatic Dis 9 (2006) 99-101
71. Cheng L., Cheville J.C., and Bostwick D.G. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol 23 (1999) 1173-1183
72. Stone N.N., Stock R.G., Unger P., et al. Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer. J Endourol 14 (2000) 375-380
73. Spiess P.E., Lee A.K., Leibovici D., et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 107 (2006) 275-280
74. Ng C.K., Moussa M., Downey D.B., et al. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol 178 (2007) 1253-1257
75. Albertsen P.C., Hanley J.A., Harlan L.C., et al. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol 163 (2000) 1138-1143
76. Sodee D.B., Malguria N., Faulhaber P., et al. Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers. Urology 56 (2000) 988-993
77. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
78. Eisenberg M.L., and Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 72 (2008) 1315-1318
79. Siddiqui S.A., Mynderse L.A., Zincke H., et al. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology 70 (2007) 80-85
80. Pisters L.L., Perrotte P., Scott S.M., et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol 17 (1999) 2514-2520
81. Izawa J.I., Ajam K., McGuire E., et al. Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol 164 (2000) 1978-1981
82. Ismail M., Ahmed S., Kastner C., et al. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 100 (2007) 760-764
83. Pisters L.L., Leibovici D., Blute M., et al. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 182 (2009) 517-525
84. Cox R.L., and Crawford E.D. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology 45 (1995) 932-935
85. Nyam D.C., and Pemberton J.H. Management of iatrogenic rectourethral fistula. Dis Colon Rectum 42 (1999) 994-997 [discussion: 997-9]
86. Coogan C.L., and McKiel C.F. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol 154 (1995) 1813-1817
87. Cohen J.K., Rooker G.M., Miller Jr. R.J., et al. Cryosurgical ablation of the prostate: treatment alternative for localized prostate cancer. Cancer Treat Res 88 (1996) 167-186
88. Long J.P., Fallick M.L., LaRock D.R., et al. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 159 (1998) 477-484
89. De La Taille A., Benson M.C., Bagiella E., et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 85 (2000) 281-286
90. Seigne J.D., Pisters L.L., and von Eschenbach A.C. Osteitis pubis as a complication of prostate cryotherapy. J Urol 156 1 (1996) 182
91. Hubosky S.G., Fabrizio M.D., Schellhammer P.F., et al. Single center experience with third- generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol 21 (2007) 1521-1531
92. Robinson J.W., Donnelly B.J., Siever J.E., et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes. Cancer 115 (2009) 4695-4704
93. Asterling S., and Greene D.R. Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer. BJU Int 103 6 (2009) 788-792
94. Janzen N.K., Han K.R., Perry K.T., et al. Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol 19 (2005) 520-525
95. Jia Z., and Davies P.L. Antifreeze proteins: an unusual receptor-ligand interaction. Trends Biochem Sci 27 (2002) 101-106